Cara Therapeutics | CARA - EPS Earnings Per Share

Stock Price
4.02
Daily Change
0 0%
Monthly
13.24%
Yearly
-70.22%
Q1 Forecast
3.87

Cara Therapeutics reported $-5.04 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.





Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Alterity Therapeutics Limited AUD 0 0 Dec/2023
Assertio Holdings USD -0.03 0.01 Sep/2024
Cara Therapeutics USD -5.04 3.24 Dec/2024
Cassava Sciences USD -0.22 0.7 Sep/2025
Chugai Pharma JPY 78.03 10.45 Dec/2025
Cipla INR 15.2 1.52 Dec/2025
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.08 0 Sep/2025
CSL USD 5.07 3 Dec/2025
Grifols EUR 0.29 0.03 Mar/2026
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
J&J USD 2.46 0.34 Dec/2025
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Pacira USD 0.06 0.64 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
RedHill Biopharma USD -1.31 33.38 Jun/2024
Supernus Pharmaceuticals USD -0.07 0.73 Dec/2025
Vanda Pharmaceuticals USD -0.09 0 Dec/2024